Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Director | May 17, 2018 | May 21, 2018 |
| SeaSpine Holdings CorpSPNE · Entity 120832 | Director | May 30, 2018 | May 31, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 17, 2018 · Filed May 21, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,569 |
Reported balance
After 2018-05-17 transaction · row 1
1 source rowRow 1 · 2018-05-17 · Grant · Acquired 2,965 · Balance 62,569 |
SeaSpine Holdings Corp
Report date May 30, 2018 · Filed May 31, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,062 |
Reported balance
After 2018-05-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-05-30 · Grant · Acquired 8,857 · Balance 48,062 F1: The restricted stock award vests in full on May 30, 2019, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation ("SeaSpine") at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting. F2: On July 1, 2015, Integra LifeSciences Holdings Corporation ("Integra") distributed 100% of the shares of common stock of SeaSpine that it owned to Integra stockholders of record as of the close ofbusiness on June 19, 2015. The distribution was made to the stockholders of Integra on a pro rata basis by means of a share dividend. Integra distributed to its stockholders one share of SeaSpine common stock for every three shares of Integra common stock held by stockholders of Integra as of the close of business on June 19, 2015. The distribution of SeaSpine shares was exempt from Section 16 of the Exchange Act by Rule 16a-9. Includes 7,220 shares of SeaSpine issued to the Reporting Person pursuant to the distribution in respect of shares of Integra held by him prior to the distribution. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock award vests in full on May 30, 2019, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation ("SeaSpine") at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting.
F2: On July 1, 2015, Integra LifeSciences Holdings Corporation ("Integra") distributed 100% of the shares of common stock of SeaSpine that it owned to Integra stockholders of record as of the close ofbusiness on June 19, 2015. The distribution was made to the stockholders of Integra on a pro rata basis by means of a share dividend. Integra distributed to its stockholders one share of SeaSpine common stock for every three shares of Integra common stock held by stockholders of Integra as of the close of business on June 19, 2015. The distribution of SeaSpine shares was exempt from Section 16 of the Exchange Act by Rule 16a-9. Includes 7,220 shares of SeaSpine issued to the Reporting Person pursuant to the distribution in respect of shares of Integra held by him prior to the distribution.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2018 Filed May 31, 2018 16:52 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 8,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000095 · wf-form4_152779991473183.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,062 F1 · shares: The restricted stock award vests in full on May 30, 2019, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation ("SeaSpine") at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting. F2 · balance_after: On July 1, 2015, Integra LifeSciences Holdings Corporation ("Integra") distributed 100% of the shares of common stock of SeaSpine that it owned to Integra stockholders of record as of the close ofbusiness on June 19, 2015. The distribution was made to the stockholders of Integra on a pro rata basis by means of a share dividend. Integra distributed to its stockholders one share of SeaSpine common stock for every three shares of Integra common stock held by stockholders of Integra as of the close of business on June 19, 2015. The distribution of SeaSpine shares was exempt from Section 16 of the Exchange Act by Rule 16a-9. Includes 7,220 shares of SeaSpine issued to the Reporting Person pursuant to the distribution in respect of shares of Integra held by him prior to the distribution. Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:53 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031923 · doc4.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,569 Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,658 | $0.00 Strike: $18.06 | $0.00 |
DisclosureSEC source: 0001209191-18-018014 · doc4.xml · derivative · entry 3 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,658 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/19/2010 F3 · balance_after: This option was previously reported as covering 7,500 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $36.12 per share. F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 15,658 | $52.56 | $822,960.99 |
DisclosureSEC source: 0001209191-18-018014 · doc4.xml · nonDerivative · entry 2 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,604 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.44 to $52.69. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 15,658 | $18.06 | $282,783.48 |
DisclosureSEC source: 0001209191-18-018014 · doc4.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 13:36 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 1,086 | $11.52 | $12,510.72 |
DisclosureSEC source: 0001637761-17-000137 · wf-form4_149927614821378.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,205 F1 · shares: This restricted stock award was issued to the reporting person under the SeaSpine Holdings Corporation 2015 Incentive Award Plan in lieu of a portion of the retainer the reporting person is entitled to receive in his capacity as a non-employee director of the issuer. The restricted stock award vests immediately on the date of grant. Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 15:26 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 15,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000125 · wf-form4_149755477380770.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,119 F1 · shares: The restricted stock award vests in four equal installments on each of September 14, 2017, December 14, 2017, March 14, 2018 and June 14, 2018, subject to the Reporting Person's continued service on the board of directors of SeaSpine Holdings Corporation ("SeaSpine") through each vesting date. F2 · balance_after: On July 1, 2015, Integra LifeSciences Holdings Corporation ("Integra") distributed 100% of the shares of common stock of SeaSpine that it owned to Integra stockholders of record as of the close ofbusiness on June 19, 2015. The distribution was made to the stockholders of Integra on a pro rata basis by means of a share dividend. Integra distributed to its stockholders one share of SeaSpine common stock for every three shares of Integra common stock held by stockholders of Integra as of the close of business on June 19, 2015. The distribution of SeaSpine shares was exempt from Section 16 of the Exchange Act by Rule 16a-9. Includes 7,220 shares of SeaSpine issued to the Reporting Person pursuant to the distribution in respect of shares of Integra held by him prior to the distribution. Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:40 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035436 · doc4.xml · nonDerivative · entry 2 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,604 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:40 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035436 · doc4.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,040 F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals on the Forms 4 filed subsequent to that date. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:50 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,658 | $0.00 Strike: $10.74 | $0.00 |
DisclosureSEC source: 0001209191-17-030369 · doc4.xml · derivative · entry 3 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,658 shares Expires 2017-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 05/20/2009. F3 · balance_after: This stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:50 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 15,658 | $45.89 | $718,573.80 |
DisclosureSEC source: 0001209191-17-030369 · doc4.xml · nonDerivative · entry 2 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,496 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $45.83 to $45.97. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:50 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 15,658 | $10.74 | $168,166.92 |
DisclosureSEC source: 0001209191-17-030369 · doc4.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 11:11 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionStock Option (right to buy) · Derivative | 2,609 | $0.00 Strike: $6.92 | $0.00 |
DisclosureSEC source: 0001637761-17-000082 · wf-form4_149321947207546.xml · derivative · entry 2 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,609 shares Expires 2017-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 11:11 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 2,609 | $6.92 | $18,054.28 |
DisclosureSEC source: 0001637761-17-000082 · wf-form4_149321947207546.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 14:06 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 1,593 | $7.85 | $12,505.05 |
DisclosureSEC source: 0001637761-17-000077 · wf-form4_149124276210367.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,389 F1 · shares: This restricted stock award was issued to the reporting person under the SeaSpine Holdings Corporation 2015 Incentive Award Plan in lieu of a portion of the retainer the reporting person is entitled to receive in his capacity as a non-employee director of the issuer. The restricted stock award vests immediately on the date of grant. F2 · balance_after: The number reported in Table 1-Item 5 of Form 4s filed by the reporting person on June 9, 2016 and thereafter has been overstated by 17 shares. This Form 4 states the corrected amount of securities beneficially owned following the reported transaction. The overstatement in those prior Form 4s was the result of the reporting person inadvertently reporting the issuance to him of an incorrect number of shares in connection with the distribution to him of shares of the issuer in connection with the spin-off of the orthobiologics and spinal hardware business of Integra LifeSciences Holdings Corporation. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 11:21 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 1,583 | $7.90 | $12,505.70 |
DisclosureSEC source: 0001637761-17-000009 · wf-form4_148354688382556.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,813 F1 · shares: The restricted stock award vests immediately on the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.